
Gate Bio
Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination.
Seed ·
Amount not disclosed in a source on record.
Funding history ↓Signals
About Gate Bio
Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
- JMJordi Mata-Fink Co-Founder and Chief Executive Officersource: gatebio.com
- RTRaman Talwar Co-Founder and Chief Technology Officersource: gatebio.com
Companies like Gate Bio
MMolecular GateSeed · Mar 2026
MMerida Biosciences$120M Series A · May 2025
AAnaveon$120M Series B+ · Dec 2021
TTRIMTECH Therapeutics$14M Seed · Jun 2026
BBlock BiosciencesPre Seed · Mar 2026
OOctant BioSeries B+ · Oct 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/gate-bio (get a free API key).